U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07177482) titled 'ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients' on Sept. 10.
Brief Summary: This study aims to investigate 68Ga-MY6349, an immune-PET tracer targeting trophoblast cell surface antigen 2 (Trop2), for the noninvasive diagnosis of craniopharyngioma in vivo.
Study Start Date: July 04
Study Type: INTERVENTIONAL
Condition:
Craniopharyngioma
Intervention:
DIAGNOSTIC_TEST: 68Ga-MY6349 PET/CT
Each subject receives a single intravenous injection of 68Ga-MY6349 and undergoes PET/CT imaging within the specified time.
Recruitment Status: RECRUITING
Sponsor: Deling Li
Information provided ...